MEDMIRA INC(TSX-V:MIR) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, MIR scores 0 out of 10 in our fundamental rating. MIR was compared to 15 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of MIR have multiple concerns. MIR has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

MIR had negative earnings in the past year.

In the past year MIR has reported a negative cash flow from operations.

In the past 5 years MIR always reported negative net income.

MIR had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -77.05%, MIR perfoms like the industry average, outperforming 57.14% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-77.05%
ROE	N/A
ROIC	N/A

ROA(3y)-58.63%

ROA(5y)-50.7%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 58.51%, MIR perfoms like the industry average, outperforming 57.14% of the companies in the same industry.

MIR's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for MIR so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	58.51%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-11.9%

GM growth 5Y-7.32%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for MIR has been increased compared to 1 year ago.

Compared to 5 years ago, MIR has more shares outstanding

MIR has a better debt/assets ratio than last year.

2.2 Solvency

MIR has an Altman-Z score of -29.14. This is a bad value and indicates that MIR is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of MIR (-29.14) is worse than 71.43% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-29.14

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.13 indicates that MIR may have some problems paying its short term obligations.

With a Current ratio value of 0.13, MIR is not doing good in the industry: 85.71% of the companies in the same industry are doing better.

A Quick Ratio of 0.12 indicates that MIR may have some problems paying its short term obligations.

Looking at the Quick ratio, with a value of 0.12, MIR is doing worse than 85.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.13
Quick Ratio	0.12

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for MIR have decreased strongly by -34.15% in the last year.

Looking at the last year, MIR shows a very negative growth in Revenue. The Revenue has decreased by -17.02% in the last year.

The Revenue has been decreasing by -4.79% on average over the past years.

EPS 1Y (TTM)-34.15%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-72.73%

Revenue 1Y (TTM)-17.02%

Revenue growth 3Y-42.27%

Revenue growth 5Y-4.79%

Sales Q2Q%-47.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MIR. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MIR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MEDMIRA INC

TSX-V:MIR (3/7/2025, 7:00:00 PM)

0.105

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)11-26 2024-11-26

Earnings (Next)03-27 2025-03-27

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners0.37%

Ins Owner ChangeN/A

Market Cap79.62M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	223.35
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.01

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0

FCFYN/A

OCF(TTM)0

OCFYN/A

SpS0

BVpS-0.03

TBVpS-0.03

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-77.05%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	58.51%
FCFM	N/A

ROA(3y)-58.63%

ROA(5y)-50.7%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-11.9%

GM growth 5Y-7.32%

F-Score2

Asset Turnover0.07

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.13
Quick Ratio	0.12
Altman-Z	-29.14

F-Score2

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-34.15%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-72.73%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-17.02%

Revenue growth 3Y-42.27%

Revenue growth 5Y-4.79%

Sales Q2Q%-47.67%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-48.37%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-96.31%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-104.8%

OCF growth 3YN/A

OCF growth 5YN/A

MEDMIRA INC (MIR.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens